Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia

NCT01701310

Conditions
Adenocarcinoma, Anemia, Carcinoma, +19 more
Locations
  • Nottingham University Hospitals NHS Trust Nottingham, United Kingdom
  • University Hospital Birmingham Birmingham, West Midlands, United Kingdom
  • Royal Wolverhampton Hospitals NHS Trust Wolverhampton, West Midlands, United Kingdom
  • University Hospitals Bristol Foundation NHS Turst Bristol, United Kingdom
View Trial Details
Completed

QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma

NCT00813605

Conditions
Adenocarcinoma, Carcinoma, Colonic Diseases, +19 more
Locations
  • Research Site Beverly Hills, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Maria, California, United States
  • Research Site Denver, Colorado, United States
View all 67 locations
View Trial Details
Completed

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

NCT00688753

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Ghent, Belgium
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lyon, France
View all 19 locations
View Trial Details
Completed

Phase I FOLFOX Combination

NCT00499850

Conditions
Adenocarcinoma, Advanced Colorectal Carcinoma, Carcinoma, +3 more
Locations
  • Research Site East Melbourne, Australia
  • Research Site Footscray, Australia
  • Research Site Heidelberg, Australia
  • Research Site Parkville, Australia
View Trial Details
Completed

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

NCT00948961

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +53 more
Locations
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions